Compare Liquidia Corporation Common Stock (LQDA) vs Omnicom Group Inc. (OMC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Liquidia Corporation Common Stock vs Omnicom Group Inc. — how do they compare? Liquidia Corporation Common Stock trades at $33.18 (market cap $3.04B), while Omnicom Group Inc. trades at $80.37 (market cap $21.51B). The key difference: Omnicom Group Inc. is far larger — about 7.1× Liquidia Corporation Common Stock's market cap, and Omnicom Group Inc. pays a 4.08% dividend while Liquidia Corporation Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Liquidia Corporation Common Stock for 0 Days and Omnicom Group Inc. for 64 Days on average.
| LQDA | OMC | |
|---|---|---|
Market Cap | $3.04B | $21.51B |
Volume | 21,111,778 | 2,093,740 |
Sector | Health | Media |
52-Week High | $91.03 | $88.94 |
52-Week Low | $22.02 | $67.27 |
Typical Hold Time | 0 Days | 64 Days |
Enterprise Value | $2.94B | $29.59B |
Dividend Yield | — | 4.08% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
OMC trades at $78.49, up 1.84% today, with a bullish technical signal but mixed earnings history. The company reported revenue growth to $17.27B in 2025, though net income was negative. Analyst consensus is a buy with a $100.50 target, supported by recent business wins and leadership in digital marketing. Cash flow improved significantly in 2025, but high P/E and debt levels warrant caution.
Outlook is cautiously optimistic given strong analyst targets and operational momentum, but risks include ad market volatility, elevated debt, and thin profit margins. The stock offers value with a low P/S ratio and dividend, yet investors must monitor earnings consistency and macroeconomic impacts on advertising spend.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Liquidia Corporation Common Stock
Liquidia Corporation is a biopharmaceutical company that develops therapies for rare cardiopulmonary diseases, including YUTREPIA, an inhaled treprostinil powder for pulmonary hypertension built on its PRINT technology.
Read more on LQDA →About Omnicom Group Inc.
Omnicom is the world's second- largest ad holding company, based on annual revenue. The firm's services, which include traditional and digital advertising and public relations, are provided worldwide, with over 85% of its revenue coming from more developed regions such as North America and Europe.
Read more on OMC →
